Acyclovir exerts a highly sensitive inhibitory action against herpes simplex types 1 and 2, Varicella - Zoster virus, Epstein-Barr virus and Cytomegalo virus. The enzyme thymidine kinase(TK) in virus-infected but not uninfected cells initiates the activation of acyclovir into the triphosphate. This interferes with viral DNA polymerase and inhibits viral duplication.
Treatment and long term suppression of herpes simplex infections of skin and mucous membranes (genital herpes simplex, mucocutaneous H.simplex and chickenpox). Prophylaxis in immuno-compromised patients. Treatment of herpes zoster. Herpes simplex encephalitis, H. simplex keratitis.
After oral administration acyclovir is excreted primarily unchanged in the urine. Hence in renal dysfunction dose is to be decreased.
Hypersensitivity to acyclovir or any component of the formulation.
After topical application irritation, burning sensation and stinging may occur. Nausea, malaise, headache. I.V. administration may cause skin rash, sweating, hypotension and vomiting. CNS effects include hallucination, seizure and coma which are due to high dose but are reversible.
Renal dysfunction.
IV Infusion :
within 24 hours.
upto 8 hours.
250mg
Injection Lyophilized - Ready for use (single vial per box),
|
||||||||||||||||||||||||||||||||||||||
|
Disclaimer
: This guide is provided for information purposes only, and for use
of a registered medical practitioner or a hospital or a laboratory only.
The authors, webmaster, or respective references / links are no way
responsible for the content of the information. Although a concerted
effort has been made to ensure the validity of the information contained
in this document, we give no
assurance for the accuracy of the information in this documents. |